ALIGN TECHNOLOGY INC
ALGNHealthcarealigntech.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Nov 4, 2026
Next reportFebruary 3, 2027after close · forecast 3.121 $/share
Revenue
$1.01B
▲ +1.9% vs prior year YoY
Net income
$135.04M
▲ +138.0% vs prior year YoY
EPS
1.90$
▲ +143.6% vs prior year YoY
Net margin
13.3%
▲ +7.6 pp vs prior year YoY
Revenue▲ +1.9%
Margins (% of revenue)GrossOperatingNet
Net income▲ +138.0%
EPS▲ +143.6%
Financial statements
View 10-Q filed November 4, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $995.22M | $979.26M | $1.01B | $995.69M | $1.05B | $1.04B | $1.06B | $1.01B | ▲ +1.9% |
| Gross profit | $696.94M | $680.11M | $708.12M | $639.20M | $683.59M | $736.59M | $757.43M | $697.47M | ▲ +9.1% |
| Operating income | $144.15M | $131.10M | $163.03M | $96.30M | $155.32M | $141.96M | $154.01M | $169.16M | ▲ +75.7% |
| Net income | $103.81M | $93.23M | $124.61M | $56.75M | $135.76M | $112.77M | $108.29M | $135.04M | ▲ +138.0% |
| R&D | $94.88M | $97.20M | $96.40M | $93.28M | $83.04M | $98.66M | $102.03M | $93.87M | ▲ +0.6% |
| EPS (diluted) | — | 1.27 $ | 1.72 $ | 0.78 $ | — | 1.57 $ | 1.51 $ | 1.90 $ | ▲ +143.6% |
| Margins (% of revenue) | |||||||||
| Gross | 70.0 % | 69.5 % | 69.9 % | 64.2 % | 65.3 % | 70.8 % | 71.7 % | 68.7 % | ▲ +4.5 pt |
| Operating | 14.5 % | 13.4 % | 16.1 % | 9.7 % | 14.8 % | 13.6 % | 14.6 % | 16.7 % | ▲ +7.0 pt |
| Net | 10.4 % | 9.5 % | 12.3 % | 5.7 % | 13.0 % | 10.8 % | 10.3 % | 13.3 % | ▲ +7.6 pt |
| Balance sheet | |||||||||
| Assets | $6.21B | $6.10B | $6.22B | $6.23B | $6.23B | $6.31B | $6.42B | $6.52B | ▲ +4.6% |
| Liabilities | $2.36B | $2.31B | $2.31B | $2.28B | $2.18B | $2.16B | $2.19B | $2.22B | ▼ -2.7% |
| Equity | $3.85B | $3.79B | $3.91B | $3.96B | $4.05B | $4.15B | $4.23B | $4.31B | ▲ +8.8% |
| Cash | $1.04B | $873.01M | $901.16M | $1.00B | $1.09B | $1.06B | $1.10B | $1.14B | ▲ +14.0% |
| Capital | |||||||||
| Shares outstanding | 73.60M | 72.48M | 72.49M | 71.75M | 71.28M | 71.62M | 71.04M | 70.49M | ▼ -1.8% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.